Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes - PubMed (original) (raw)

Randomized Controlled Trial

. 2017 Feb 16;376(7):641-651.

doi: 10.1056/NEJMoa1600869.

Affiliations

Randomized Controlled Trial

Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes

Philip R Schauer et al. N Engl J Med. 2017.

Abstract

Background: Long-term results from randomized, controlled trials that compare medical therapy with surgical therapy in patients with type 2 diabetes are limited.

Methods: We assessed outcomes 5 years after 150 patients who had type 2 diabetes and a body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) of 27 to 43 were randomly assigned to receive intensive medical therapy alone or intensive medical therapy plus Roux-en-Y gastric bypass or sleeve gastrectomy. The primary outcome was a glycated hemoglobin level of 6.0% or less with or without the use of diabetes medications.

Results: Of the 150 patients who underwent randomization, 1 patient died during the 5-year follow-up period; 134 of the remaining 149 patients (90%) completed 5 years of follow-up. At baseline, the mean (±SD) age of the 134 patients was 49±8 years, 66% were women, the mean glycated hemoglobin level was 9.2±1.5%, and the mean BMI was 37±3.5. At 5 years, the criterion for the primary end point was met by 2 of 38 patients (5%) who received medical therapy alone, as compared with 14 of 49 patients (29%) who underwent gastric bypass (unadjusted P=0.01, adjusted P=0.03, P=0.08 in the intention-to-treat analysis) and 11 of 47 patients (23%) who underwent sleeve gastrectomy (unadjusted P=0.03, adjusted P=0.07, P=0.17 in the intention-to-treat analysis). Patients who underwent surgical procedures had a greater mean percentage reduction from baseline in glycated hemoglobin level than did patients who received medical therapy alone (2.1% vs. 0.3%, P=0.003). At 5 years, changes from baseline observed in the gastric-bypass and sleeve-gastrectomy groups were superior to the changes seen in the medical-therapy group with respect to body weight (-23%, -19%, and -5% in the gastric-bypass, sleeve-gastrectomy, and medical-therapy groups, respectively), triglyceride level (-40%, -29%, and -8%), high-density lipoprotein cholesterol level (32%, 30%, and 7%), use of insulin (-35%, -34%, and -13%), and quality-of-life measures (general health score increases of 17, 16, and 0.3; scores on the RAND 36-Item Health Survey ranged from 0 to 100, with higher scores indicating better health) (P<0.05 for all comparisons). No major late surgical complications were reported except for one reoperation.

Conclusions: Five-year outcome data showed that, among patients with type 2 diabetes and a BMI of 27 to 43, bariatric surgery plus intensive medical therapy was more effective than intensive medical therapy alone in decreasing, or in some cases resolving, hyperglycemia. (Funded by Ethicon Endo-Surgery and others; STAMPEDE ClinicalTrials.gov number, NCT00432809 .).

PubMed Disclaimer

Figures

Figure 1

Figure 1. Mean Changes in Measures of Diabetes Control from Baseline to 5 Years

Shown are the mean glycated hemoglobin levels (Panel A), the percent change in diabetes medications during the study period (Panel B), the changes in body-mass index (BMI, the weight in kilograms divided by the square of the height in meters) (Panel C), and the mean glycated hemoglobin levels according to BMI (Panel D) over a 5-year period among patients receiving intensive medical therapy alone, those who underwent sleeve gastrectomy, and those who underwent a gastric bypass procedure. ⌶ bars indicate standard errors. Mean values in each group are provided below the graphs; in Panels A and D, median values are also provided in parentheses. P values for the comparison between each surgical group and the medical-therapy group in Panels A, C, and D were derived from overall treatment effect in the repeated measurements model. In Panel D, P<0.001 for the comparison between the surgical groups and the medical-therapy group for the subgroup of patients with a BMI of less than 35; P<0.01 for the comparison for the subgroup with a BMI of 35 or more.

Comment in

Similar articles

Cited by

References

    1. Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–52. - PMC - PubMed
    1. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg. 2003;238:467–85. - PMC - PubMed
    1. Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98:1763–77. - PubMed
    1. Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311:2297–304. - PubMed
    1. Arterburn DE, Olsen MK, Smith VA, et al. Association between bariatric surgery and long-term survival. JAMA. 2015;313:62–70. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources